| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2781 | |||||||||||||||||||||||
| Submitter : | Mrs. Doris Chasse | Date & Time: | 12/08/2006 09:12:52 | |||||||||||||||||||||
| Organization : | Mrs. Doris Chasse | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I wish to express my displeasure with the need to use ABORTED FETAL CELL LINES in your development of new vaccines; especially when ethical cell lines such as bacteria, insect cell lines and chick embryos are available. | ||||||||||||||||||||||||